Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
This product is not FDA approved for human use, is classified as an unapproved substance by the World Anti-Doping Agency, and is not intended for human consumption
Reduced Inflammation Research demonstrates BPC-157 modulates inflammatory pathways, reducing levels of pro-inflammatory cytokines while promoting anti-inflammatory responses
The strongest clinical use cases are musculoskeletal injuries, gut lining integrity, and systemic inflammation
129 In studies using 3T3-L1 cells, resveratrol treatment significantly decreased lipid accumulation, down-regulated the expression of C/EBP, LPL, FAS, and SREBP-1c through activation of AMPK, 130 decreased phosphorylation of MAPKs, and reduced Rb phosphorylation, 131 suppressed hormonal-induced AKT activation and cell proliferation, and inhibited cell entry into the S phase and the S to the G2/M phase transition
If future trials confirm long-term benefits, C-peptide therapy could become a standard part of comprehensive diabetes management
US$ 23.15
US$ 29.37
US$ 28.48
US$ 26.41
